On behalf of IPOPI, we are writing to thank you for your invaluable contribution to the Second International Primary Immunodeficiencies Congress (IPIC2015) which took place in Budapest on 5-6 November 2015.
Your participation has greatly contributed to the success of the conference and we are very honoured and grateful to have counted you amongst our key speakers and chairpersons.
The feedback received so far has been extremely positive. We are delighted to have witnessed a significant increase (over 70%) in participation since the first congress, with close to 700 participants and over 70 countries represented this year in Budapest.
In 2017 we will build on these outcomes and travel to Dubai with the aim to continue promoting clinical advances in the field and helping improve access to diagnosis and appropriate treatment for people living with a primary immunodeficiency worldwide through the congress.
IPIC2017 will provide an excellent opportunity to strengthen the dialogue between the key PID stakeholders including patients, physicians, nurses and industry partners in a new region and we hope to have you once again with us for this important next step.
Please note that congress presentations (for which we have received permission to do so) will soon be published on the congress website along with a congress report.
With our renewed thanks and good wishes,
Mrs. Jose Drabwell Mr. Johan Prévot
Chair, IPOPI Board Executive Director, IPOPI